Canlyniadau Chwilio - Cebon, J.

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide gan Cebon, J

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer. gan Cebon, J. S., Bishop, J. F., Harvey, V., Mason, B., Jeal, P. N.

Cael y testun llawn Cael y testun llawn

Interleukin-4 suppresses granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in stimulated human monocytes. gan Hamilton, J A, Whitty, G A, Royston, A K, Cebon, J, Layton, J E

Cael y testun llawn Cael y testun llawn

Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia. gan Waring, P M, Presneill, J, Maher, D W, Layton, J E, Cebon, J, Waring, L J, Metcalf, D

Cael y testun llawn Cael y testun llawn

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. gan Stanley, E, Lieschke, G J, Grail, D, Metcalf, D, Hodgson, G, Gall, J A, Maher, D W, Cebon, J, Sinickas, V, Dunn, A R

Cael y testun llawn Cael y testun llawn

Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications gan Sigalotti, L, Coral, S, Altomonte, M, Natali, L, Gaudino, G, Cacciotti, P, Libener, R, Colizzi, F, Vianale, G, Martini, F, Tognon, M, Jungbluth, A, Cebon, J, Maraskovsky, E, Mutti, L, Maio, M

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy gan Bowyer, S, Prithviraj, P, Lorigan, P, Larkin, J, McArthur, G, Atkinson, V, Millward, M, Khou, M, Diem, S, Ramanujam, S, Kong, B, Liniker, E, Guminski, A, Parente, P, Andrews, M C, Parakh, S, Cebon, J, Long, G V, Carlino, M S, Klein, O

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Multiplex immunohistochemistry accurately defines the immune context of metastatic melanoma gan Halse, H., Colebatch, A. J., Petrone, P., Henderson, M. A., Mills, J. K., Snow, H., Westwood, J. A., Sandhu, S., Raleigh, J. M., Behren, A., Cebon, J., Darcy, P. K., Kershaw, M. H., McArthur, G. A., Gyorki, D. E., Neeson, P. J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Somatostatin receptor expression, tumour response and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide gan Cebon, J, Findlay, M, Hargreaves, C, Stockler, M, Thompson, P, Boyer, M, Roberts, S, Poon, A, Scott, A M, Kalff, V, Garas, G, Dowling, A, Crawford, D, Ring, J, Basser, R, Strickland, A, Macdonald, G, Green, M, Nowak, A, Dickman, B, Dhillon, H, Gebski, V

Cael y testun llawn Cael y testun llawn

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma gan Wolchok, J.D., Chiarion-Sileni, V., Gonzalez, R., Rutkowski, P., Grob, J.-J., Cowey, C.L., Lao, C.D., Wagstaff, J., Schadendorf, D., Ferrucci, P.F., Smylie, M., Dummer, R., Hill, A., Hogg, D., Haanen, J., Carlino, M.S., Bechter, O., Maio, M., Marquez-Rodas, I., Guidoboni, M., McArthur, G., Lebbé, C., Ascierto, P.A., Long, G.V., Cebon, J., Sosman, J., Postow, M.A., Callahan, M.K., Walker, D., Rollin, L., Bhore, R., Hodi, F.S., Larkin, J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn